Status:
UNKNOWN
Prolonged Symptoms and Reasons for Consultation in Town Medicine Associated With COVID-19 Infection in the Hauts de France Region
Lead Sponsor:
Tourcoing Hospital
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
Several publications document the occurrence of prolonged or late-onset symptoms beyond 3 weeks after the first clinical manifestations of SARS-COV2 infection. These manifestations may be related to t...
Eligibility Criteria
Inclusion
- A- For COVID cases:
- Consultation in a city doctor's office
- Positive SARS-CoV-2 RT-PCR result OR positive SARS-CoV-2 serology
- Patient symptomatic or not
- Definition of symptomatic :
- Anosmia
- OR CT scan suggestive of COVID 19
- OR ≥ 2 symptoms contemporaneous with virologic sampling among: asthenia, cough, dyspnea, fever, myalgias, dysgeusia, diarrhea AND not present previously at diagnosis
- B-. For NON COVID cases:
- Consultation in a city doctor's office
- No known COVID+ serology
- No known RT- PCR SARS-CoV-2
- No clinical suspicion of COVID-19 infection
Exclusion
- Minor patient
- Refusal to participate
- Patient under protection
- Patient requiring hospitalization for COVID-19 (excluding non-emergency hospitalization)
- Patient consulted for the following reason only: treatment monitoring, treatment renewal or certificate, hospital discharge
Key Trial Info
Start Date :
April 6 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2023
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04817293
Start Date
April 6 2021
End Date
February 1 2023
Last Update
May 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CH Tourcoing
Tourcoing, France